International Business News - AFFY http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Affymax Inc. and Japanese partner Takeda Pharmaceutical Co. said Thursday they will cut part of their development program for the anemia drug candidate Hematide and continue focusing on its possible use in kidney disease patients. http://www.ibtimes.com/articles/20080828/affymax-ends-part-of-hematide-development-program.htm Thu, 28 Aug 2008 16:23:49 EDT Shares of Affymax Inc. fluctuated wildly Wednesday after an analyst predicted success for the company's drug candidate Hematide as a treatment for anemia caused by kidney disease. http://www.ibtimes.com/articles/20080702/affymax-wavers-on-forecast-of-hematide-approval.htm Wed, 02 Jul 2008 17:39:51 EDT